An in vitro cell-based potency assay for pharmaceutical type A botulinum antitoxins
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Israel Institute for Biological Research (SB-146)
This publication has 31 references indexed in Scilit:
- Botulinum Neurotoxin Serotype a Specific Cell-Based Potency Assay to Replace the Mouse BioassayPLOS ONE, 2012
- Novel Application of Human Neurons Derived from Induced Pluripotent Stem Cells for Highly Sensitive Botulinum Neurotoxin DetectionToxicological Sciences, 2012
- Sensitive and quantitative detection of botulinum neurotoxin in neurons derived from mouse embryonic stem cellsBiochemical and Biophysical Research Communications, 2010
- Development of Cell-Based Assays to Measure Botulinum Neurotoxin Serotype A Activity Using Cleavage-Sensitive AntibodiesSLAS Discovery, 2010
- Isolation and Chimerization of a Highly Neutralizing Antibody Conferring Passive Protection against Lethal Bacillus anthracis InfectionPLOS ONE, 2009
- A neuronal cell‐based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodiesFEBS Letters, 2007
- Botulism Diagnostics: From Clinical Symptoms toin vitroAssaysCritical Reviews in Microbiology, 2007
- SV2 Is the Protein Receptor for Botulinum Neurotoxin AScience, 2006
- Novel application of an in vitro technique to the detection and quantification of botulinum neurotoxin antibodiesJournal of Immunological Methods, 2004
- Botulinum A Toxin Therapy: Neutralizing and Nonneutralizing Antibodies—Therapeutic ConsequencesExperimental Neurology, 1997